1. Home
  2. IHD vs ACOG Comparison

IHD vs ACOG Comparison

Compare IHD & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Emerging Markets High Income Dividend Equity Fund

IHD

Voya Emerging Markets High Income Dividend Equity Fund

N/A

Current Price

$7.71

Market Cap

135.9M

Sector

Finance

ML Signal

N/A

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$9.53

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IHD
ACOG
Founded
2011
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.9M
193.6M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
IHD
ACOG
Price
$7.71
$9.53
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
81.9K
162.7K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
10.32%
N/A
EPS Growth
N/A
41.58
EPS
N/A
N/A
Revenue
N/A
$10,220,275.00
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.93
$4.50
52 Week High
$8.14
$10.14

Technical Indicators

Market Signals
Indicator
IHD
ACOG
Relative Strength Index (RSI) 56.06 58.07
Support Level $7.07 $5.28
Resistance Level $7.69 $10.14
Average True Range (ATR) 0.08 0.55
MACD 0.01 -0.04
Stochastic Oscillator 80.00 51.61

Price Performance

Historical Comparison
IHD
ACOG

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: